A new drug could prove at least twice as effective in treating Alzheimer’s disease as current medications and significantly slow the progression of dementia, researchers say.
The research team at the University of Aberdeen concluded that the drug, Rember, slows progression of the disease by up to 81 per cent.
Sufferers taking the drug three times a day for 50 weeks showed a slower decline in blood flow to the parts of the memory that are vital to the memory.
Experts hailed the study as a major development in the fight against Alzheimer’s, which affects an estimated 350,000 people in Britain and more than 26 million people worldwide.
Watch Alzheimers by Youtube :
Watch Alzheimers by Youtube :